Literature DB >> 11316071

Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance.

M Takatsuki1, S Uemoto, Y Inomata, S Sakamoto, M Hayashi, M Ueda, T Kanematsu, K Tanaka.   

Abstract

Although some previous studies have indicated the possibility of immunosuppression withdrawal in clinical liver transplantation, the mechanism of graft acceptance is not clear. The aim of this study is to elucidate the alloreactivity against the donor and intragraft cytokine profiles in living donor liver transplant (LDLT) recipients with graft acceptance. In October 1999, we had 23 patients who survived without immunosuppression after LDLT with a median drug-free period of 25 months (range: 3-69 months). They consisted of six patients who were electively weaned by an elective weaning protocol and 17 either forcibly or accidentally weaned patients due to various causes but mainly due to infection. We evaluated the alloreactivity against the donor in these patients by a mixed lymphocyte reaction and intragraft cytokine profiles by real-time reverse transcriptase-polymerase chain reaction. The development of donor-specific hyporeactivity was observed in the patients with graft acceptance. The cytokine pattern in the supernatant of the culture medium revealed a down regulation of T helper (Th) 1 cytokine INF gamma against the donor while no significant difference was seen in Th2 cytokine IL-10. Regarding the intragraft cytokine profiles, we could find no amplification of Thl cytokines (IL-2, INF y) and IL-4 while some of the patients revealed a gene expression of IL-10 with no significant difference from that of the normal, untransplanted liver specimen. In addition, no difference was observed in any other cytokines (IL-1beta, IL-8, IL-15, TNFalpha) compared with those of the normal controls. We propose that the down regulation of Th1 cytokine is one possible mechanism of graft acceptance in LDLT recipients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316071     DOI: 10.1016/s0966-3274(01)00027-2

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  9 in total

1.  Marking a path to transplant tolerance.

Authors:  Vicki Seyfert-Margolis; Laurence A Turka
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

2.  Translational lessons from a case of combined heart and liver transplantation for familial hypercholesterolemia 20 years post-operatively.

Authors:  Michael Ibrahim; Ismail El-Hamamsy; Mahmoud Barbir; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2011-09-01       Impact factor: 4.132

Review 3.  Tolerance in clinical transplantation: progress, challenge or just a dream?

Authors:  Fred Fändrich
Journal:  Langenbecks Arch Surg       Date:  2011-03-17       Impact factor: 3.445

4.  Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients.

Authors:  Udeme D Ekong; Xunrong Luo; Min Yu; Delli Wang; Stephen D Miller; Maurice R G O'Gorman
Journal:  Hum Immunol       Date:  2011-02-26       Impact factor: 2.850

5.  Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation.

Authors:  Pervinder Sagoo; Giovanna Lombardi; Robert I Lechler
Journal:  Front Immunol       Date:  2012-07-13       Impact factor: 7.561

Review 6.  Clinical significance of Th17 cells in kidney transplantation.

Authors:  Byung Ha Chung; Chul Woo Yang; Mi-La Cho
Journal:  Korean J Intern Med       Date:  2018-05-31       Impact factor: 2.884

Review 7.  Strategies for Liver Transplantation Tolerance.

Authors:  Filip Cvetkovski; J Mark Hexham; Erik Berglund
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

Review 8.  Clinical and Basic Research Progress on Treg-Induced Immune Tolerance in Liver Transplantation.

Authors:  Xuhao Ni; Qi Wang; Jian Gu; Ling Lu
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

9.  Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression.

Authors:  Byung Ha Chung; Kyoung Woon Kim; Bo-Mi Kim; Shang Guo Piao; Sun Woo Lim; Bum Soon Choi; Cheol Whee Park; Yong-Soo Kim; Mi-La Cho; Chul Woo Yang
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.